UroGen Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$7.3M
Doctors Paid
7,252
Transactions
25,229
2024 Total
$1.7M
Payment Breakdown by Category
Research$1.7M (22.9%)
Food & Beverage$763,178 (10.4%)
Consulting$649,663 (8.9%)
Travel$157,085 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.0M | 76 | 41.4% |
| Unspecified | $1.7M | 778 | 22.9% |
| Honoraria | $980,904 | 293 | 13.4% |
| Food and Beverage | $763,178 | 23,056 | 10.4% |
| Consulting Fee | $649,663 | 235 | 8.9% |
| Travel and Lodging | $157,085 | 365 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $34,400 | 11 | 0.5% |
| Gift | $30,250 | 74 | 0.4% |
| Education | $4,327 | 341 | 0.1% |
Payments by Type
General
$5.7M
24,451 transactions
Research
$1.7M
778 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| UROGEN BL-006 | $472,488 | 0 | 188 |
| UROGEN PHARMA BL007 | $156,290 | 0 | 91 |
| UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | $104,235 | 3 | 19 |
| UTRACT JELMYTO REGISTRY A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER UTUC TREATED WITH JELMYTO UTRACT | $96,448 | 0 | 7 |
| QUALITY OF CARE AND COST-ANALYSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA | $89,568 | 0 | 2 |
| UROGEN BL006 | $56,875 | 0 | 320 |
| BL007 - A ROLLOVER STUDY TO FOLLOW THE LONG-TERM OUTCOMES OF PATIENTS FROM STUDY UT001 (FORMERLY TC-UT-03) AND STUDY TC-BC-12 | $33,087 | 0 | 56 |
| OLYMPUS | $19,214 | 0 | 36 |
| UROGEN BL010 | $13,079 | 0 | 22 |
| OLYMPUS FINAL MANUSCRIPT | $9,152 | 26 | 26 |
| BL010 | $1,306 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Arie Belldegrun, Md, MD | Urology | Los Angeles, CA | $1.3M | $0 |
| Dr. Stuart Holden | Urology | Los Angeles, CA | $667,538 | $0 |
| Dr. Fred Cohen, M.d, M.D | Internal Medicine | San Francisco, CA | $657,884 | $0 |
| Dr. Leana Wen, M.d., M.sc, M.D., M.SC | Emergency Medicine | Baltimore, MD | $491,485 | $0 |
| Katie Murray, D.o, D.O | Urology | New York, NY | $346,917 | $0 |
| Karim Chamie, M.d, M.D | Surgical Oncology | Los Angeles, CA | $123,736 | $0 |
| Vahan Kassabian, M.d, M.D | Urology | Roswell, GA | $88,981 | $0 |
| Yair Lotan, Md, MD | Urology | Dallas, TX | $80,782 | $0 |
| Gary Steinberg, M D, M D | Urology | Chicago, IL | $76,141 | $0 |
| Dr. Jennifer Linehan, M.d, M.D | Urology | Santa Monica, CA | $74,784 | $0 |
| Dr. Sandip Prasad, Md, Mphil, MD, MPHIL | Urology | Charleston, SC | $73,300 | $0 |
| Ravi Munver, M.d, M.D | Urology | Hackensack, NJ | $67,334 | $0 |
| Solomon Woldu, M.d, M.D | Urology | Dallas, TX | $44,563 | $0 |
| Dr. Alan Nieder | Urology | Miami Beach, FL | $35,027 | $0 |
| Rian Dickstein, Md, MD | Urology | Hanover, MD | $30,175 | $0 |
| Dr. Vignesh Packiam, M.d, M.D | Urology | Iowa City, IA | $29,833 | $0 |
| Dr. Adam Feldman, Md, MD | Urology | Boston, MA | $27,709 | $0 |
| Jason Hafron, Md, MD | Urology | West Bloomfield, MI | $25,598 | $0 |
| Jonathan Epstein, M.d, M.D | Anatomic Pathology & Clinical Pathology | Baltimore, MD | $24,750 | $0 |
| Dr. Zachary Klaassen, M.d, M.D | Urology | Augusta, GA | $23,620 | $0 |
| Brian Hu, Md, MD | Urology | Loma Linda, CA | $23,218 | $0 |
| Dr. Vitaly Margulis, Md, MD | Urology | Dallas, TX | $20,966 | $0 |
| Sam Chang, Md, MD | Urology | Nashville, TN | $18,665 | $0 |
| Dr. Kyle Basham, Md, MD | Urology | Fort Smith, AR | $18,578 | $0 |
| Trinity Bivalacqua, Md Phd, MD PHD | Urology | Philadelphia, PA | $18,231 | $0 |
About UroGen Pharma, Inc.
UroGen Pharma, Inc. has made $7.3M in payments to 7,252 healthcare providers, recorded across 25,229 transactions in the CMS Open Payments database. In 2024, the company paid $1.7M. The top product by payment volume is JELMYTO ($2.3M).
Payments were distributed across 99 medical specialties. The top specialty by payment amount is Urology ($4.0M to 4,184 doctors).
Payment categories include: Food & Beverage ($763,178), Consulting ($649,663), Research ($1.7M), Travel & Lodging ($157,085).
UroGen Pharma, Inc. is associated with 1 products in the CMS Open Payments database.